Budgeting for Opioid Addiction Treatment Act

Summary

Budgeting for Opioid Addiction Treatment Act This bill amends the Internal Revenue Code, with respect to excise taxes on manufacturers, to impose a one cent per milligram fee on the sale of active opioids by the manufacturer, producer, or importer. The fee excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort. The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do not pay the fee. The bill amends the Public Health Service Act to require any increase in federal revenues from the fee after rebates and discounts are subtracted to be distributed to states under the Substance Abuse Prevention and Treatment Block Grant program. The states must use the funds exclusively for substance abuse (including opioid abuse) efforts in the states, including: (1) specified treatment programs, and (2) the recruitment and training of substance use disorder professionals to work in rural and medically underserved communities. HHS must report to Congress on the impact of this bill on the retail cost of opioids and patient access to opioid medication, the effectiveness of the discount or rebate for cancer and hospice patients, how the funds are being used to improve substance abuse treatment efforts, and suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 2 March 2017

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 2 March 2017

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 2 March 2017 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 2 March 2017

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 2 March 2017

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 2 March 2017

  Open at official source

Sponsors

• Sen. Manchin, Joe, III [I-WV] · D · Sponsor
• Amy Klobuchar · D · Sponsor
• Sen. Heitkamp, Heidi [D-ND] · D · Sponsor
• Rep. Nelson, Bill [D-FL-11] · D · Sponsor
• Angus King · I · Sponsor
• Christopher Murphy · D · Sponsor
• Tammy Baldwin · D · Sponsor
• Elizabeth Warren · D · Sponsor
• Maggie Hassan · D · Sponsor
• Jeanne Shaheen · D · Sponsor
• Richard Blumenthal · D · Cosponsor
• Sheldon Whitehouse · D · Cosponsor
• Tina Smith · D · Cosponsor
• · ssfi00 · Standing

Related records

• related to → Budgeting for Opioid Addiction Treatment Act
• related to ← Budgeting for Opioid Addiction Treatment Act